These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
167 related articles for article (PubMed ID: 28464965)
1. Risk of transition to schizophrenia following first admission with substance-induced psychotic disorder: a population-based longitudinal cohort study. Alderson HL; Semple DM; Blayney C; Queirazza F; Chekuri V; Lawrie SM Psychol Med; 2017 Oct; 47(14):2548-2555. PubMed ID: 28464965 [TBL] [Abstract][Full Text] [Related]
2. Substance-induced psychoses converting into schizophrenia: a register-based study of 18,478 Finnish inpatient cases. Niemi-Pynttäri JA; Sund R; Putkonen H; Vorma H; Wahlbeck K; Pirkola SP J Clin Psychiatry; 2013 Jan; 74(1):e94-9. PubMed ID: 23419236 [TBL] [Abstract][Full Text] [Related]
3. Characteristics and outcomes of young people with substance induced psychotic disorder. O'Connell J; Sunwoo M; McGorry P; O'Donoghue B Schizophr Res; 2019 Apr; 206():257-262. PubMed ID: 30471979 [TBL] [Abstract][Full Text] [Related]
4. Prediction of Onset of Substance-Induced Psychotic Disorder and Its Progression to Schizophrenia in a Swedish National Sample. Kendler KS; Ohlsson H; Sundquist J; Sundquist K Am J Psychiatry; 2019 Sep; 176(9):711-719. PubMed ID: 31055966 [TBL] [Abstract][Full Text] [Related]
5. Short-term outcome of substance-induced psychotic disorder in a large UK first episode psychosis cohort. Thompson A; Marwaha S; Winsper C; Everard L; Jones PB; Fowler D; Amos T; Freemantle N; Singh SP; Marshall M; Sharma V; Birchwood M Acta Psychiatr Scand; 2016 Oct; 134(4):321-8. PubMed ID: 27479903 [TBL] [Abstract][Full Text] [Related]
6. First-episode drug-induced psychosis: a medium term follow up study reveals a high-risk group. Crebbin K; Mitford E; Paxton R; Turkington D Soc Psychiatry Psychiatr Epidemiol; 2009 Sep; 44(9):710-5. PubMed ID: 19183816 [TBL] [Abstract][Full Text] [Related]
7. Rates and Predictors of Conversion to Schizophrenia or Bipolar Disorder Following Substance-Induced Psychosis. Starzer MSK; Nordentoft M; Hjorthøj C Am J Psychiatry; 2018 Apr; 175(4):343-350. PubMed ID: 29179576 [TBL] [Abstract][Full Text] [Related]
8. The epidemiology and progression time from transient to permanent psychiatric disorders of substance-induced psychosis in Taiwan. Chen WL; Hsieh CH; Chang HT; Hung CC; Chan CH Addict Behav; 2015 Aug; 47():1-4. PubMed ID: 25841087 [TBL] [Abstract][Full Text] [Related]
9. Differentiating first episode substance induced and primary psychotic disorders with concurrent substance use in young people. Fraser S; Hides L; Philips L; Proctor D; Lubman DI Schizophr Res; 2012 Apr; 136(1-3):110-5. PubMed ID: 22321667 [TBL] [Abstract][Full Text] [Related]
10. Differences between substance-induced psychotic disorders and non-substance-induced psychotic disorders and diagnostic stability. Cambra Almerge J; Sánchez-Romero S; Arias Horcajadas F Adicciones; 2023 Jul; 35(2):95-106. PubMed ID: 36975062 [TBL] [Abstract][Full Text] [Related]
11. Clinical characteristics of primary psychotic disorders with concurrent substance abuse and substance-induced psychotic disorders: A systematic review. Wilson L; Szigeti A; Kearney A; Clarke M Schizophr Res; 2018 Jul; 197():78-86. PubMed ID: 29117908 [TBL] [Abstract][Full Text] [Related]
12. Psychiatric Hospitalizations of Chronic Psychotic Disorder Patients With and Without Dual Diagnosis, Israel, 1963-2016. Florentin S; Rosca P; Raskin S; Bdolah-Abram T; Neumark Y J Dual Diagn; 2019; 15(3):130-139. PubMed ID: 31079564 [No Abstract] [Full Text] [Related]
13. Substance-induced psychotic disorders: 13-year data from a de-addiction centre and their clinical implications. Aggarwal M; Banerjee A; Singh SM; Mattoo SK; Basu D Asian J Psychiatr; 2012 Sep; 5(3):220-4. PubMed ID: 22981049 [TBL] [Abstract][Full Text] [Related]
14. Transition to Schizophrenia Spectrum Disorder Following Emergency Department Visits Due to Substance Use With and Without Psychosis. Myran DT; Harrison LD; Pugliese M; Solmi M; Anderson KK; Fiedorowicz JG; Perlman CM; Webber C; Finkelstein Y; Tanuseputro P JAMA Psychiatry; 2023 Nov; 80(11):1169-1174. PubMed ID: 37755727 [TBL] [Abstract][Full Text] [Related]
15. Annual incidence of cannabis-induced psychosis, other substance-induced psychoses and dually diagnosed schizophrenia and cannabis use disorder in Denmark from 1994 to 2016. Hjorthøj C; Larsen MO; Starzer MSK; Nordentoft M Psychol Med; 2021 Mar; 51(4):617-622. PubMed ID: 31839011 [TBL] [Abstract][Full Text] [Related]
16. Real world clinical outcomes of treatment of cannabis-induced psychosis and prevalence of cannabis-related primary psychosis: a retrospective study. Chuenchom O; Suansanae T; Lukanapichonchut L; Suwanmajo S; Suthisisang C BMC Psychiatry; 2024 Sep; 24(1):626. PubMed ID: 39334053 [TBL] [Abstract][Full Text] [Related]
17. [Differential diagnostic distinction between substance-induced and primary psychoses: : Recommendations for general psychiatric and forensic practice]. Hirjak D; Meyer-Lindenberg A; Brandt GA; Dreßing H Nervenarzt; 2022 Jan; 93(1):11-23. PubMed ID: 33656571 [TBL] [Abstract][Full Text] [Related]
18. [Is there a temporal correlation between substance abuse and psychosis in adolescents?]. Holtmann M; Becker K; Hartmann M; Schmidt MH Z Kinder Jugendpsychiatr Psychother; 2002 May; 30(2):97-103. PubMed ID: 12053879 [TBL] [Abstract][Full Text] [Related]
20. Cannabis use and psychotic disorders: an update. Hall W; Degenhardt L; Teesson M Drug Alcohol Rev; 2004 Dec; 23(4):433-43. PubMed ID: 15763748 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]